1. Introduction

Climate Migration and Biotech Access Rights is an emerging interdisciplinary legal topic examining the rights of people displaced by climate change to access biotechnology-related healthcare, genetic services, vaccines, medicines, reproductive healthcare, and other essential biological interventions.

Climate change can force people to migrate because of rising sea levels, droughts, extreme heat, floods, wildfires, and food or water insecurity. Displacement may disrupt medical treatment, vaccination programmes, maternal healthcare, disease surveillance, and access to medicines that require reliable storage or specialist facilities.

Biotechnology adds a further legal dimension: whether displaced persons, refugees, stateless people, and climate-affected communities can obtain essential biomedical services without discrimination based on nationality, immigration status, poverty, or place of residence.

Important legal qualification: This is a developing field rather than a single, universally recognised legal doctrine. The analysis below draws on established refugee law, human rights law, environmental law, public health law, and biotechnology regulation. The cases are relevant by analogy or directly applicable to particular issues; they do not all establish a specific right to biotechnology for climate migrants.

2. Meaning and scope

A. Climate migration

Climate migration refers to human mobility associated with environmental changes and climate-related disasters. It can be:

Internal displacement: Movement within a person's own country.

Cross-border displacement: Movement into another country.

Planned relocation: Organised movement from areas that have become unsafe or uninhabitable.

Slow-onset migration: Movement caused by gradual sea-level rise, desertification, salinisation, or prolonged drought.

Disaster displacement: Movement following floods, cyclones, extreme heat, or other sudden events.

People displaced by climate change are not automatically recognised as refugees under the 1951 Refugee Convention. Refugee status generally requires the Convention's criteria to be satisfied, including a well-founded fear of persecution for a specified reason. Other forms of international or domestic protection may apply.

B. Biotechnology access rights

Biotechnology access rights concern legal and ethical protections relating to access to services such as:

Vaccines, biologic medicines, and advanced therapies.

Diagnostic testing, including molecular and genomic diagnostics.

Reproductive and maternal healthcare involving biomedical technologies.

Disease screening and treatment for displaced populations.

Genetic counselling and clinically justified genetic testing.

Assistive biomedical technologies and rehabilitation.

Medical records, informed consent, and protection of genetic and health data.

These rights do not mean that every person has an unconditional entitlement to every experimental or expensive biotechnology. Access is shaped by medical need, safety, evidence of effectiveness, resource availability, and applicable law.

3. Principal legal issues

Right to health and essential treatment

Climate-displaced people may need continuity of vaccination, insulin or biologic medicines, infectious-disease testing, reproductive healthcare, and other essential services. States must consider applicable human rights obligations and avoid unjustified discrimination.

Equality and non-discrimination

A person's displacement or immigration status may create practical barriers to healthcare. Whether a distinction is lawful depends on the governing treaty, constitutional rules, and the nature of the service.

Biosafety and public health

Emergency distribution of vaccines, biological medicines, diagnostic kits, or other technologies must still satisfy applicable quality, safety, licensing, and pharmacovigilance requirements.

Genetic privacy and informed consent

Displaced populations must not be treated as convenient research subjects. Genetic data collection and biomedical research require appropriate legal authority, meaningful consent where required, safeguards against misuse, and protection from exploitation.

4. Major international case laws

Case 1: Ioane Teitiota v. New Zealand (2020)

United Nations Human Rights Committee · Communication No. 2728/2016 · CCPR/C/127/D/2728/2016

Facts: Ioane Teitiota, a national of Kiribati, sought protection in New Zealand, arguing that climate change, rising sea levels, land scarcity, and freshwater contamination made returning to Kiribati unsafe.

Legal issue: Could returning a person to a country affected by climate change violate the right to life under Article 6 of the International Covenant on Civil and Political Rights (ICCPR)?

Decision: The Human Rights Committee did not find a violation in Teitiota's individual case. However, it recognised that climate-related conditions can, in sufficiently serious circumstances, trigger a state's obligation not to return a person to a country where there is a real risk of irreparable harm to rights protected by Articles 6 or 7 of the ICCPR.

Refworld+1

Relevance to biotechnology access rights:

Return decisions should account for serious foreseeable threats to life and health.

Evidence concerning access to essential medicines, vaccines, diagnostic services, and safe water may be relevant to assessing the conditions faced by a returnee.

The case does not establish a separate right to receive biotechnology or automatically prohibit the return of climate migrants.

Legal principle: Climate change may engage international human rights protection even where the affected person does not qualify as a refugee under the traditional Refugee Convention framework.

Case 2: Daniel Billy and Others v. Australia (2022)

UN Human Rights Committee · Communication No. 3624/2019 · CCPR/C/135/D/3624/2019

Facts: Indigenous Torres Strait Islanders complained that inadequate Australian climate adaptation measures threatened their homes, traditional livelihoods, culture, and way of life.

Legal issue: Can inadequate climate adaptation measures violate fundamental human rights before people are forced to leave their homes?

Decision: The Human Rights Committee found violations relating to arbitrary interference with private life, family, and home under Article 17, and the right to enjoy one's culture under Article 27 of the ICCPR. It did not find a violation of Article 6 on the evidence presented.

University College Cork+2

Relevance to biotechnology access rights:

Climate adaptation must account for the needs of particularly vulnerable communities.

Healthcare infrastructure and continuity of treatment can form part of a broader adaptation strategy.

Community participation matters when planning relocation, health programmes, and technology-based interventions.

Genetic or biomedical interventions must not replace meaningful protection of land, culture, and community autonomy.

Legal principle: States have human rights responsibilities to protect communities against foreseeable climate-related harm, including certain harms to home and culture.

Case 3: Pabai v. Commonwealth of Australia (No 2) (2025)

Federal Court of Australia · [2025] FCA 796 · Judgment of 15 July 2025

Facts: Torres Strait Islanders brought a representative proceeding alleging that the Australian Commonwealth failed to take reasonable steps to protect them against climate change.

Decision: The Federal Court did not establish the alleged common-law duties of care concerning emissions targets and climate adaptation funding. The decision illustrates the difficulties of converting broad climate protection responsibilities into specific, enforceable negligence duties.

CaseChat AU+2

Relevance: A claim that a government must fund a particular biotechnology programme for climate-displaced people would similarly need a recognised legal basis, an identifiable duty, evidence of harm, and a legally available remedy. The case does not decide whether a biotechnology-access right exists.

Comparative significance

5. Applicable international legal framework

A. International Covenant on Economic, Social and Cultural Rights (ICESCR)

The ICESCR is central to healthcare access.

Article 12: Recognises the right to the highest attainable standard of physical and mental health.

Article 2(2): Prohibits discrimination in the enjoyment of Covenant rights.

Article 15: Protects interests relating to scientific progress and its applications.

These provisions support arguments for non-discriminatory access to essential healthcare and the benefits of scientific progress. They do not guarantee immediate access to every advanced or experimental therapy. The precise duties depend on the applicable obligations, including progressive realisation and the requirement to take appropriate steps.

B. International Covenant on Civil and Political Rights (ICCPR)

Relevant protections include:

Article 6: Right to life.

Article 7: Protection against torture and cruel, inhuman, or degrading treatment.

Article 17: Protection against arbitrary interference with privacy, family, and home.

Article 26: Equality before the law and equal protection without discrimination.

These provisions may apply to climate-displaced persons, depending on jurisdiction and the circumstances. They can be relevant to forced medical procedures, discriminatory denial of services, and unlawful handling of sensitive genetic information.

C. 1951 Refugee Convention and 1967 Protocol

Climate displacement alone does not automatically confer refugee status. However, a person affected by climate change may qualify if the relevant legal requirements are satisfied, including persecution linked to a Convention ground.

Other legal protections may be available through human rights law, regional frameworks, national immigration law, or disaster-displacement policies.

D. Paris Agreement

The Paris Agreement establishes an international framework for climate mitigation and adaptation. Its preamble calls on parties to respect, promote, and consider their human rights obligations when taking climate action.

It supports integrating public health, adaptation, and vulnerability considerations into climate planning. It does not itself create a general individual entitlement to a particular biotechnology treatment.

6. Indian constitutional law and relevant case laws

For India, the strongest legal approach is to combine climate-related constitutional rights with established protections for health, equality, and access to essential medical care.

Case 4: M.K. Ranjitsinh v. Union of India (2024)

Supreme Court of India · 2024 INSC 280 · Judgment dated 21 March 2024

Facts: The case concerned conservation of the Great Indian Bustard and the effects of overhead power transmission infrastructure, including the relationship between wildlife protection and renewable energy development.

Decision: The Supreme Court recognised a right to be free from the adverse effects of climate change, grounded in Articles 14 and 21 of the Constitution of India. It also explained how climate change can affect health, equality, food security, water security, and vulnerable communities.

National Digital Library of India+1

Application to climate migration and biotechnology:

Article 21 provides a constitutional foundation for arguments concerning health and human dignity.

Article 14 may support challenges to arbitrary or discriminatory denial of essential services.

Climate-related health programmes should consider the unequal burdens borne by displaced and underserved communities.

The judgment does not expressly recognise a fundamental right to every biotechnology product or treatment.

This is a particularly important Indian authority because it links climate protection with constitutional rights rather than treating climate change exclusively as an environmental policy issue.

Case 5: Paschim Banga Khet Mazdoor Samity v. State of West Bengal (1996)

Supreme Court of India · (1996) 4 SCC 37

Facts: A worker who had suffered a serious head injury encountered difficulties obtaining emergency medical treatment at government hospitals.

Decision: The Supreme Court held that failure by government hospitals to provide timely emergency medical treatment could violate Article 21. The State has an obligation to establish an adequate system for providing emergency medical services.

Madhya Pradesh High Court

Application: Where climate displacement causes a person to lose access to urgent treatment, the case may support a claim concerning the State's medical-care obligations. For example, a displaced patient who cannot obtain emergency treatment or a medically essential biological medicine may invoke relevant constitutional protections.

The case does not establish an automatic entitlement to a specific advanced therapy; the nature of the treatment, urgency, applicable duties, and evidence remain important.

Case 6: Parmanand Katara v. Union of India (1989)

Supreme Court of India · (1989) 4 SCC 286

Legal principle: Doctors and medical institutions have an obligation to provide necessary emergency medical aid to preserve life, subject to the applicable legal framework.

Application: A climate-displaced person who requires immediate medical intervention should not be denied emergency assistance merely because the person's long-term immigration or resettlement status is unresolved.

The case supports emergency medical access, not an unrestricted right to experimental biotechnology.

Madhya Pradesh High Court

7. What specific biotechnology access rights should climate migrants have?

The following framework is a proposed rights-based approach derived from existing legal principles, not a statement that all these rights are already expressly guaranteed by law.

A crucial distinction is that access to essential healthcare is not the same as a right to genetic enhancement, experimental treatment, or unrestricted access to patented technologies.

8. Biotechnology, migration, and the principal legal risks

A. Discrimination in access

Governments or healthcare providers may create barriers through documentation requirements, residence rules, language barriers, or fees.

A legal challenge would examine whether the restriction has a legitimate basis, whether it is discriminatory or disproportionate, and what obligations apply to the relevant state or provider.

B. Medical continuity across borders

Climate migrants may lose access to specialist care when crossing borders. Biological medicines can also require temperature-controlled transport and storage.

Appropriate legal and administrative measures include:

Portable medical records with suitable privacy safeguards.

Emergency medicine supplies and reliable cold-chain systems.

Recognition or verification of prescriptions across participating jurisdictions.

Referral systems between receiving and sending healthcare facilities.

C. Genetic exploitation

Climate-displaced communities may be vulnerable to research involving genetic samples, disease susceptibility, or population-level biological data.

Legal safeguards should include independent ethical review, valid informed consent where required, limits on secondary use, secure storage, and appropriate community consultation. Displacement must never be treated as a substitute for consent.

D. Intellectual property and affordability

Patents and regulatory exclusivities can affect the price and availability of advanced medicines. Patent law, public procurement, voluntary licensing, and lawful compulsory licensing may each affect access.

The legal question is how to reconcile innovation incentives with public health needs and applicable international and domestic intellectual property rules. Climate displacement does not automatically cancel patent rights.

E. Relocation and long-term care

When relocation is unavoidable, authorities should assess whether the receiving location can support people's essential medical needs. A relocation plan that provides shelter but leaves patients without critical treatment may raise serious health and human rights concerns.

9. Duties of governments and other institutions

Governments

Establish accessible health services, protect against discrimination, prepare for climate-related health emergencies, and comply with applicable constitutional and international obligations.

Healthcare providers

Maintain appropriate standards of care, safeguard medical information, and ensure continuity of clinically necessary treatment.

Biotechnology companies

Comply with medicine-safety, manufacturing, data-protection, clinical-trial, and other applicable regulatory requirements.

International organisations

Support coordinated humanitarian health responses, technical assistance, appropriate medicine procurement, and cooperation between countries.

These responsibilities arise from different sources of law and policy. A company, humanitarian organisation, or foreign state does not automatically bear the same legal duties as the person's own government.

10. Remedies and enforcement

Depending on the jurisdiction and the nature of the violation, potential remedies include:

Constitutional proceedings: In India, eligible claimants may seek appropriate relief under Articles 32 or 226 where fundamental rights and jurisdictional requirements are satisfied.

Administrative review: Challenge unlawful denial of healthcare, discriminatory eligibility rules, or improper migration decisions.

Human rights complaints: Use available international or regional complaint mechanisms when jurisdiction, admissibility, and other procedural conditions are met.

Compensation: Seek damages where an applicable legal basis and the necessary elements of liability are established.

Injunctive or declaratory relief: Request orders addressing unlawful restrictions or failures to comply with enforceable duties.

Data-protection remedies: Challenge unlawful collection, use, or disclosure of medical or genetic information under applicable law.

A successful claim normally requires identification of the responsible authority or defendant, the relevant legal duty, evidence of the denial or harm, and a remedy the court or tribunal is empowered to grant.

11. A proposed legal doctrine

A possible framework for this emerging field could be called the Climate-Displacement Biotechnology Equity Principle.

It would have five components:

Non-discrimination: Climate displacement should not by itself justify denying essential, otherwise available healthcare.

Medical continuity: Relocation and migration systems should protect access to clinically necessary treatment.

Biosafety: Emergency access must remain compatible with medicine quality and patient safety.

Data autonomy: Genetic and biomedical information must be protected from exploitation.

Equitable adaptation: Governments should integrate healthcare access into climate adaptation and resettlement planning.

This is a proposed analytical framework, not an established, independently binding rule of international law.

12. Conclusion

Climate migration and biotechnology access rights sit at the intersection of climate justice, healthcare, migration law, privacy, and biomedical regulation.

The most useful authorities for developing the argument are Teitiota v. New Zealand for climate-related non-refoulement, Billy v. Australia for climate adaptation and human rights, and M.K. Ranjitsinh v. Union of India for India's constitutional protection against adverse climate effects. Paschim Banga Khet Mazdoor Samity and Parmanand Katara provide additional support for arguments concerning emergency medical care.

Taken together, these authorities provide a foundation for arguing that climate-displaced persons should receive meaningful protection of life, health, equality, privacy, and dignity. The more ambitious claim—that every climate migrant has a specific, enforceable right to any biotechnology—is not established by these decisions and would require further statutory, constitutional, or treaty-based support.

For a deeper legal study, the next useful step would be to develop a case-law research matrix comparing India, international human rights law, and refugee law, with each judgment's facts, holding, legal principle, and relevance to biotechnology access.